Smoking-genotype interaction for T2D and FG: Europeans

Dataset

Download summary statistics | Download README

Publications

Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose.
Wu P, et al.
PLoS One 2020 May 7;15(5):e0230815. doi: 10.1371/journal.pone.0230815.
PMID:32379818

Dataset phenotypes

  • Smoking-fasting glucose interaction
  • Smoking-fasting glucose interaction, joint 2-degree-of-freedom test
  • Smoking-fasting glucose interaction, main effect model
  • Smoking-T2D interaction
  • Smoking-T2D interaction, joint 2-degree-of-freedom test
  • Smoking-T2D interaction, main effect model

Dataset subjects

Subjects Cohort Ancestry
8,659 Atherosclerosis Risk in Communities Study (ARIC) European
1,248 Coronary Artery Risk Development in Young Adults Study (CARDIA) European
3,347 Cardiovascular Health Study (CHS) European
2,978 Framingham Heart Study (FHS) European
2,124 Multi-Ethnic Study of Atherosclerosis (MESA) European

Experiment summary

This study is a gene-environment-wide interaction study (GEWIS) to identify potential gene-by-smoking interactions for incident type 2 diabetes and baseline fasting glucose. In the Portal, associations from this study are displayed in 5 datasets:

  • Smoking-genotype interaction for T2D and FG: African Americans
  • Smoking-genotype interaction for T2D and FG: Europeans
  • Smoking-genotype interaction for T2D and FG: African Americans, ever-smokers
  • Smoking-genotype interaction for T2D and FG: Europeans, ever-smokers
  • Smoking-genotype interaction for T2D and FG: African Americans, never-smokers
  • Smoking-genotype interaction for T2D and FG: Europeans, never-smokers

 

Dataset ID
GWAS_SmokingT2D_eu